Use of continuous glucose monitoring system in patients with type 2 mellitus diabetic during hemodialysis treatment.

Background: Studies highlight the inaccuracy of glycated hemoglobin (HbA1c) for the assessment of glycemic control in dialysis diabetics and suggest the use of continuous glucose monitoring (CGM) as an alternative. Of the CGMs, FreeStyle Libre is the most used in worldwide, but there is still no consensus on its use in dialysis.

Method: A 3-week prospective study was performed with 12 patients comparing capillary and interstitial glucose during dialysis.